banner ad

Watch broker Movie Ad
Deposition Designation Station

Academic Physician Expert Mark Levin

Dr. Mark Levin
6 Gel Court
Monsey NY 10952
phone: 845-406-2183
Dr. Mark Levin, MD, is an Academic Physician with a wide range of experience in various practice settings, including academia, teaching hospital and private practice settings. He has a consulting practice in clinical standards and utilization review in Oncology and runs a blog devoted to Standards of Care. He is in active medical practice.

Services Include:
  • Administrative Medicine
  • Brain Tumors
  • Breast Cancer
  • Cancer - Missed Diagnosis
  • Chemotherapy
  • Experimental / Investigational Medicine
  • Hematology
  • Improper Diagnosis
  • Kidney Cancer
  • Lung Cancer
  • Medical Practice Guidelines
  • Medical Records Review
  • Medical Utilization Review
  • Mesothelioma and other Asbestos Lung Diseases
  • Oncology
  • Pain Management
  • Prognosis (Cancer)
  • Standard of Care
  • Tumor Marker Testing
  • 12/26/2012 · Robots & Robotics
    Safe and effective chronic opioid therapy for chronic cancer related pain requires clinical skills and knowledge in both the principles of opioid prescribing and on the assessment and management of risks associated with opioid abuse, addiction, and diversion.

    Breast cancer patients often suffer menopausal symptoms, which include vaginal dryness. This distressing symptom is often treated with topical estrogen or progesterone creams; however, there remains a concern about systemic absorption of estrogen and its effect on breast cancer. In a group that is treated with tamoxifen, it would appear that the systemic affect would be negated by the tamoxifen's anti-estrogen blockade but the question remains hotly debated.

    4/3/2009 · Medical
    Breast cancer is a malignant (cancerous) growth that begins in the tissues of the breast. Over the course of a lifetime, one in eight women will be diagnosed with breast cancer

    9/23/2008 · Medical
    Acceptance and compliance with screening and genetic programs for genetic illness depends crucially on the compatibility and fit of their design with the social, cultural and religious concerns and mores of target communities. As a case in point, genetic screening programs that are currently in use within Jewish populations are considered on the background of ethical and religious concerns